Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
Cetirizine hydrochloride
Actavis Group PTC ehf
R06AE; R06AE07
Cetirizine hydrochloride
10 milligram(s)
Film-coated tablet
Product not subject to medical prescription
Piperazine derivatives; cetirizine
Marketed
2006-07-07
PACKAGE LEAFLET: INFORMATION FOR THE USER CETRIZ 10 MG FILM-COATED TABLETS Cetirizine dihydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse after 3 days. WHAT IS IN THIS LEAFLET: 1 WHAT CETRIZ IS AND WHAT IT IS USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE CETRIZ 3 HOW TO TAKE CETRIZ 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE CETRIZ 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 WHAT CETRIZ IS AND WHAT IT IS USED FOR Cetirizine dihydrochloride is the active ingredient of Cetriz 10 mg Film-coated Tablets. Cetriz 10 mg Film-coated Tablets are an anti allergic medication. In adults and children aged 6 years and above, Cetriz 10 mg Film-coated Tablets are indicated: • for the relief of symptoms of hayfever (seasonal allergic rhinitis) and allergies such as dust or pet allergies (perennial allergic rhinitis) such as sneezing, itchy, runny and blocked nose, red and watery eyes. • for the relief of swelling, redness and itchiness of the skin (symptoms of chronic idiopathic urticaria, which is also known as chronic nettle rash). You must talk to a doctor if you do not feel better or if you feel worse after 3 days. 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE CETRIZ DO NOT TAKE CETRIZ • if you are allergic to cetirizine, to any of the other ingredients of this medicine (listed in section 6), to hydroxyzine or to drugs from the piperazine family, for example buclizine, cyclizine, meclozine, levocetirizine. • if you have a severe kidney disease (severe renal failure with creatinine clearanc Baca dokumen lengkap
Health Products Regulatory Authority 27 August 2021 CRN00CFX6 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cetriz 10mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains cetirizine dihydrochloride 10 mg. Excipients with known effect: contains lactose monohydrate 117.00 mg. For the full list of excipients, see 6.1. 3 PHARMACEUTICAL FORM Film coated tablet. Film-coated, white or almost white convex, oval shaped, tablets. Scored on one side. The tablet can be divided into 2 equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cetirizine dihydrochloride 10 mg film-coated tablets are indicated in adults and paediatric patients 6 years and above: - for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis. - for the relief of symptoms of chronic idiopathic urticaria. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Posology Adults and adolescents over 12 years of age: 10 mg once daily (1 tablet). Special population _Elderly_ Data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal. _Renal impairment_ There are no data to document the efficacy/ safety ratio in patients with renal impairment. Since cetirizine is mainly excreted via renal route (see section 5.2), in case no alternative treatment can be used, the dosing intervals must be individualised according to renal function. Refer to the following table and adjust the dose as indicated. To use this dosing table, an estimate of the patient's creatinine clearance (CLcr) in ml/min is needed. The CLcr (ml/min) may be estimated from serum creatinine (mg/dl) determination using the following formula: Dosing adjustments for adult patients with impaired renal function Group Creatinine clearance (ml/min) Dosage and frequency Normal ≥80 10 mg once daily Health Products Regulatory Authority 27 August 2021 CRN00CFX6 Page 2 of 8 Mild 50 – 79 10 mg once daily Moderate 30 – 49 5 mg once daily Baca dokumen lengkap